1. Home
  2. BCE vs WAT Comparison

BCE vs WAT Comparison

Compare BCE & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCE Inc.

BCE

BCE Inc.

HOLD

Current Price

$25.74

Market Cap

21.5B

Sector

N/A

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$321.68

Market Cap

22.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCE
WAT
Founded
1880
1958
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
21.5B
22.5B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
BCE
WAT
Price
$25.74
$321.68
Analyst Decision
Hold
Buy
Analyst Count
2
19
Target Price
$29.50
$394.17
AVG Volume (30 Days)
3.9M
1.3M
Earning Date
02-05-2026
02-09-2026
Dividend Yield
4.94%
N/A
EPS Growth
3698.16
0.47
EPS
4.95
10.76
Revenue
$17,845,265,182.00
$3,165,286,000.00
Revenue This Year
$4.71
$7.35
Revenue Next Year
$1.24
$6.39
P/E Ratio
$5.21
$30.05
Revenue Growth
0.24
6.99
52 Week Low
$20.28
$275.05
52 Week High
$26.49
$414.15

Technical Indicators

Market Signals
Indicator
BCE
WAT
Relative Strength Index (RSI) 59.97 24.01
Support Level $25.44 $305.35
Resistance Level $25.95 $337.83
Average True Range (ATR) 0.45 12.09
MACD -0.05 -7.24
Stochastic Oscillator 51.29 14.97

Price Performance

Historical Comparison
BCE
WAT

About BCE BCE Inc.

BCE provides wireless, broadband, television, and landline phone services in Canada. It is one of the Big Three national wireless carriers, with over 10 million customers constituting about 30% of the market. It is also the incumbent local exchange carrier—the legacy telephone provider—throughout much of the eastern half of Canada, including in the most populous Canadian provinces: Ontario and Quebec. BCE has a media segment that holds television, radio, and digital media assets. BCE licenses the Canadian rights to HBO Max and Starz.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: